首页> 中国专利> 光损伤调控物在制备用于抑制由紫外线引起的光损伤的药物中的用途

光损伤调控物在制备用于抑制由紫外线引起的光损伤的药物中的用途

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明提供一种脯氨酸、4-羟基脯氨酸、或其烷基酯在制备用于抑制由紫外线引起的光损伤的药物中的用途。

著录项

公开/公告号CN1298321C

专利类型发明授权
公开/公告日2007-02-07

原文格式PDF
申请/专利权人亚利桑那大学董事会;
展开▼

申请/专利号CN03808776.6
发明设计人 G·T·翁德拉克;M·J·罗伯茨;M·金;M·K·雅各布森;E·L·雅各布森;
展开▼

申请日2003-04-17
分类号
代理机构中科专利商标代理有限责任公司;
代理人王旭
地址美国亚利桑那州
入库时间 2022-08-23 08:59:24

法律信息

法律状态公告日

法律状态信息

法律状态
2007-02-07

授权

授权
2005-09-21

实质审查的生效

实质审查的生效
2005-07-27

公开

公开

相似文献

专利
中文文献
外文文献

1. 光损伤调控物在制备用于抑制由紫外线引起的光损伤的药物中的用途 [P] . 中国专利： CN1298321C . 2007.02.07
2. 钠－氢离子交换器抑制剂用于制备药物的用途,该药物用于预防由于年老而引起的器官机能障碍和由于年老而引起的疾病以及用于延长寿命 [P] . 中国专利： CN1367689A . 2002-09-04
3. Marker gene pool, method for assessing the reparative and / or therapeutic protective effects of ultraviolet radiation of a compound or material, compound or material having ultraviolet protective, repairing or therapeutic effects, methods for improving and / or treating, for reversing and / or repair photo-damaged or photo-aged skin, and to assess whether a substance can repair or reverse the effects of photo-damage or photoaging related to UV radiation exposure, substance or material having photo-repairing or reversing effects or photoaging, composition or formulation, photoprotective or photoprotective or anti-photoaging formulation, methods for assessing skin damage or an ultraviolet-induced skin replacement following exposure to uv radiation, to prevent photoaged or photoavariated skin, to identify or select individuals who are susceptible useful or highly sensitive to skin photoaging or photoaging following exposure to UV radiation, and kit for assessing the photoaging or photoag [P] . BR0209510A . 2006-02-07

机译：标记基因库，评估化合物或材料的紫外线的修复和/或治疗保护作用的方法，具有紫外线保护，修复或治疗作用的化合物或材料，改善和/或治疗，逆转和/或修复的方法光损伤或光老化的皮肤，并评估一种物质是否可以修复或逆转与紫外线辐射，光修复或逆转作用或光老化，组成或配方有关的物质或材料的光损伤或光老化的影响，光保护或光保护或抗光老化制剂，评估暴露于uv辐射后皮肤损伤或紫外线引起的皮肤置换，预防光老化或光变皮肤，鉴定或选择对皮肤光老化有用或高度敏感的个体的方法暴露于紫外线辐射后发生光老化，以及用于评估光老化或光敏性的试剂盒
4. composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion [P] . BRPI0617987A2 . 2011-08-16

机译：组合物，药物组合物，泡腾剂型，多单位口服口服药物组合物，缓释药物剂型，肠溶衣药物剂型，向哺乳动物受试者口服给药的稳定药物剂型，通过抑制胃酸治疗疾病的方法酸分泌，治疗由幽门螺杆菌引起或引起的细菌感染的方法，制备式3化合物的方法，制备式5化合物的方法，式1化合物在制备用于治疗胃的药物中的用途通过抑制胃酸分泌来治疗与酸有关的疾病，将式1的化合物用于制备用于治疗由幽门螺杆菌引起或引起的细菌感染的药物，或将式1的化合物用于制备用于治疗的药物通过抑制胃酸分泌来治疗胃酸相关疾病
5. compound, pharmaceutical composition, use of a compound for the preparation of a medicament for the treatment of a condition resulting from an abnormality of nitric oxide production, use of a compound for the preparation of a medicament for the treatment of pain in an individual with need thereof and use of a compound for the preparation of a medicament for the treatment of inhibition of dimerization of inos [P] . BRPI0518096A . 2008-10-28

机译：化合物，药物组合物，该化合物在制备用于治疗由一氧化氮产生异常导致的病症的药物中的用途，该化合物在制备用于治疗有需要的个体中的疼痛的药物中的用途化合物及其在制备药物中的用途，所述药物用于抑制肌苷二聚化